CIK 0001690585 · Non-accelerated filer<br>Smaller reporting company
Dianthus Therapeutics, Inc. /DE/
Sign in to watch- Ticker
- DNTH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 929-999-4055
- Business address
- 7 TIMES SQUARE, 43RD FLOOR, NEW YORK, NY, 10036
- Former names
- Magenta Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $16,043,610
- in 4 filings, $16.0M under 10b5-1 plans
Net −$16,043,610. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-22 | Read Simon Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2025-03-04 | KANGO SUJAY Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2025-02-03 | CARR EDWARD CHIEF ACCOUNTING OFFICER | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2025-02-03 | Veness Adam M SVP, General Counsel and Sec. | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2025-02-03 | Randhawa Simrat CHIEF MEDICAL OFFICER | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2025-02-03 | Savitz Ryan CFO & CBO | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2025-02-03 | Garcia Marino CEO AND PRESIDENT | Grant or award · Stock Option (Right to Buy) | +340,000 | 340,000 | ||
| 2024-09-27 | Fairmount Funds Management LLC Director | Other disposition | −62,146 | 0 | ||
| 2024-09-16 | Romano Steven J. Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2024-05-23 | CARR EDWARD CHIEF ACCOUNTING OFFICER | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2024-05-23 | Veness Adam M SVP, General Counsel and Sec. | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2024-05-23 | Randhawa Simrat CHIEF MEDICAL OFFICER | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2024-05-23 | Savitz Ryan CFO & CBO | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2024-05-23 | Garcia Marino CEO AND PRESIDENT | Grant or award · Stock Option (Right to Buy) | +243,000 | 243,000 | ||
| 2024-05-23 | Violin Jonathan Director | Grant or award · Stock Option (Right to Buy) | +11,000 | 11,000 | ||
| 2024-05-23 | Soteropoulos Paula Director | Grant or award · Stock Option (Right to Buy) | +11,000 | 11,000 | ||
| 2024-05-23 | MOULDER LEON O JR Director | Grant or award · Stock Option (Right to Buy) | +11,000 | 11,000 | ||
| 2024-05-23 | McGeorge Anne Director | Grant or award · Stock Option (Right to Buy) | +11,000 | 11,000 | ||
| 2024-05-23 | Lawton Alison Frances Director | Grant or award · Stock Option (Right to Buy) | +11,000 | 11,000 | ||
| 2024-05-23 | Fairmount Funds Management LLC Director | Grant or award · Stock Option (Right to Buy) | +11,000 | 11,000 |
Page 11 of 24 · 470 trades